Strides Pharma Science has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026, to the stock exchanges. The filing, made pursuant to Regulation 34(2)(f) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, details the company's environmental, social, and governance (ESG) performance. The report has undergone limited assurance verification by DNV Business Assurance India Private Limited.

Environmental Performance

The company reported a total energy consumption of 280,288,004,402 KJ for FY26, with 44.19% derived from renewable sources. Total Scope 1 and Scope 2 greenhouse gas emissions stood at 25,380.03 metric tonnes of CO2 equivalent. Water consumption for the year was recorded at 190,297.69 kilolitres, while total waste generated amounted to 1,910.28 metric tonnes. Of the total waste generated, 1,207.40 metric tonnes were recovered through recycling and other recovery operations, achieving a recovery rate of 63.21%.

Social and Governance Metrics

Strides Pharma Science employed a total workforce of 5,394 individuals, comprising 2,810 employees and 2,584 workers. The report highlighted a Lost Time Injury Frequency Rate (LTIFR) of 0.11 for employees, with zero fatalities recorded across the organization. The company spent 0.44% of its total revenue on well-being measures for employees and workers. Gross wages paid to females constituted 16% of the total wages paid by the entity.

Operational and Financial Disclosures

The company reported exports contributing 90.66% to its total turnover on a standalone basis. It conducted supplier assessments for 50 critical suppliers, accounting for 73.5% of its direct procurement value. The report also noted that the company is a signatory to the United Nations Global Compact and holds several ISO certifications, including ISO 14001, ISO 45001, and ISO 50001.

The report confirms compliance with applicable environmental laws and regulations, including the Water Act, Air Act, and Environment Protection Act. No fines or penalties were reported for non-compliance with these regulations during the financial year.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE939A01011/23f499a925d84a6a.pdf

Strides Pharma Science Limited has convened its 35th Annual General Meeting (AGM) on Friday, August 14, 2026, at 12:15 hrs IST through Video Conferencing (VC) / Other Audio-Visual Means (OAVM), in compliance with circulars issued by the Ministry of Corporate Affairs (MCA) and the Securities and Exchange Board of India (SEBI). The company has fixed Friday, July 31, 2026 as the record date to determine shareholder eligibility for a final dividend of ₹5 per equity share — representing 50% of the face value of ₹10 per share — for the financial year ended March 31, 2026. The dividend, recommended by the Board of Directors on May 18, 2026, is subject to shareholder approval at the AGM. If approved, the payout will be made within 30 days from the date of declaration through permissible electronic modes, after applicable tax deductions at source.

Key AGM Event Dates

The following table summarises the critical dates and details relating to the 35th AGM:

Ordinary and Special Business at the AGM

The AGM agenda covers both ordinary and special business. Under ordinary business, shareholders will consider adoption of audited financial statements for FY 2025-26, declaration of the final dividend, and the re-appointment of Mr. Arun Kumar (DIN: 00084845) — Founder, Non-Executive Director and Chairperson — who retires by rotation and offers himself for re-appointment. Under special business, shareholders will vote on the following key proposals:

Board Transition and Director Profiles

Aditya Arun Kumar, aged approximately 37 years, transitioned from his role as Executive Director – Business Development to a Non-Executive Director effective June 1, 2026, in line with the promoters' stated objective of professionalising management. He holds a bachelor's degree in biomedical sciences from Newcastle University and a Master of Research in Biophysics from King's College, London, and has over 13 years of experience in the pharmaceutical industry. As at the date of the AGM Notice, Aditya holds 58,422 equity shares (~0.06% of paid-up capital).

Ram, aged approximately 53 years, has been associated with the Strides Group since 2007 and was appointed Chief Operating Officer (COO) effective March 1, 2024. He holds a post-graduate degree in Pharmaceutical Chemistry from BITS Pilani and brings over 30 years of pharmaceutical industry experience. His proposed remuneration as Executive Director includes a fixed pay of ₹3.60 crores per annum and variable pay of ₹1.44 crores per annum, with long-term incentives linked to manufacturing, supply chain leadership, ESG integration, and digital transformation goals over his three-year tenure. As at the date of the AGM Notice, Ram holds 44,000 equity shares (~0.048% of paid-up capital) and 20,000 stock options exercisable during FY27 and FY28.

FY 2025-26 Financial Highlights

The company reported strong consolidated financial performance for FY 2025-26, as summarised below:

The total dividend payout, if approved, would amount to approximately ₹461 million, representing a payout ratio of 25% on a standalone basis and 8% on a consolidated basis. Net debt stood at ₹14,365 million as at March 31, 2026, with the net debt-to-equity ratio improving to 0.46x from 0.59x in FY25. Return on Capital Employed (ROCE) improved to 15.76% in FY26 from 14.86% in FY25.

E-voting and Participation

Shareholders whose names appear in the Register of Members as on the cut-off date of August 7, 2026 are entitled to vote on the resolutions. Remote e-voting is available via KFin Technologies Limited at https://evoting.kfintech.com/ . Shareholders may also attend the AGM through VC/OAVM using the same credentials. Speaker registration for the AGM is open from August 10, 2026 (09:00 hrs IST) to August 12, 2026 (17:00 hrs IST). The scrutinizer for the AGM is Mr. Gigi Joseph K J, Practicing Company Secretary (ICSI Membership No. F6483), and results will be declared on or before August 18, 2026. The AGM Notice and Annual Report for FY 2025-26 are available on the company's website at www.strides.com and on the websites of BSE Limited and National Stock Exchange of India Limited.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE939A01011/be7da544-ba43-45ae-8762-0d03cda330a0.pdf